The MAPK/ERK signaling pathway is another crucial target for inhibitors. Inhibitors targeting MAPK/ERK are used in cancer therapies to protect against unchecked cell expansion and tumor development.Antibiotics are a subset of inhibitors that have transformed the monitoring of bacterial infections. By targeting bacterial cell walls, protein synthesi… Read More